ACA

Acorn Capital Advisors Portfolio holdings

AUM $197M
1-Year Est. Return 25.29%
This Quarter Est. Return
1 Year Est. Return
+25.29%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$197M
AUM Growth
+$44.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
22
New
Increased
Reduced
Closed

Top Buys

1
+$3.29M
2
+$1.14M
3
+$409K

Top Sells

1
+$15.4M
2
+$1.61M
3
+$51K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CGON icon
1
CG Oncology
CGON
$3.17B
$45.6M 23.14%
1,131,501
URGN icon
2
UroGen Pharma
URGN
$1.08B
$25.1M 12.76%
1,259,749
PBYI icon
3
Puma Biotechnology
PBYI
$285M
$21.9M 11.14%
4,131,299
TRVI icon
4
Trevi Therapeutics
TRVI
$1.63B
$19.6M 9.96%
2,144,844
TERN icon
5
Terns Pharmaceuticals
TERN
$4.33B
$14.8M 7.52%
1,971,264
CADL icon
6
Candel Therapeutics
CADL
$305M
$13.2M 6.68%
2,580,517
BCAX
7
Bicara Therapeutics
BCAX
$993M
$10.2M 5.16%
643,382
OKUR
8
OnKure Therapeutics
OKUR
$40.6M
$7.81M 3.96%
2,839,674
TARA icon
9
Protara Therapeutics
TARA
$285M
$7.62M 3.87%
1,752,115
VSTM icon
10
Verastem
VSTM
$590M
$6.88M 3.49%
779,498
CYBN
11
Cybin
CYBN
$356M
$4.31M 2.19%
734,394
CRDF icon
12
Cardiff Oncology
CRDF
$170M
$4.04M 2.05%
1,962,084
+553,317
AURA icon
13
Aura Biosciences
AURA
$370M
$3.68M 1.87%
595,744
BCAB icon
14
BioAtla
BCAB
$44.3M
$3.34M 1.69%
4,835,111
JSPR icon
15
Jasper Therapeutics
JSPR
$54.8M
$3.29M 1.67%
+1,382,640
WHWK
16
Whitehawk Therapeutics
WHWK
$122M
$2.16M 1.1%
1,139,363
QTTB icon
17
Q32 Bio
QTTB
$37.3M
$1.59M 0.81%
803,425
XFOR icon
18
X4 Pharmaceuticals
XFOR
$315M
$935K 0.47%
273,349
+119,619
ACRV icon
19
Acrivon Therapeutics
ACRV
$69.1M
$733K 0.37%
405,237
VYNE icon
20
VYNE Therapeutics
VYNE
$19.3M
$199K 0.1%
586,572
-150,000
MURA
21
DELISTED
Mural Oncology
MURA
– –
-653,779
YMAB
22
DELISTED
Y-mAbs Therapeutics
YMAB
– –
-3,418,995